Know Cancer

or
forgot password
  • cancer clinical trials in middletown, OH

  • Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Home-Based Programs for Improving Sleep in Cancer Survivors
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Cancer Survivor, Fatigue, Psychosocial Effects of Cancer and Its Treatment, Sleep Disorders
    A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung
    Signal Point Clinical Research Center, LLC
    Middletown, Ohio 45042
    Metastatic or Recurrent Squamous Cell Carcinoma of the Lung
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Breast Cancer, Cardiac Toxicity
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Colorectal Cancer, Precancerous Condition
    Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
    Signal Point Hematology Oncology, Inc.
    Middletown, Ohio 45042
    Multiple Myeloma
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    Signal Point Clinical Research Center
    Middletown, Ohio 45042
    Renal Cell Carcinoma
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
    Signal Point Clinical Research Center
    Middletown, Ohio 45042
    Palmar-Plantar Erythrodysesthesia, Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Kidney Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Breast Cancer
    Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
    Signal Point Clinical Research Center, LLC
    Middletown, Ohio 45042
    Non-Squamous Non-Small Cell Lung Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Breast Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Signal Point Clinical Research Center, LLC
    Middletown, Ohio 45042
    Chronic Myeloid Leukemia
    NP2 Enkephalin For Treatment of Intractable Cancer Pain
    Signal Point Clinical Research Center
    Middletown, Ohio 45042
    Intractable Pain, Neoplasms
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Lymphoma
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Signal Point Clinical Research Center, LLC
    Middletown, Ohio 45042
    Non Small Cell Lung Cancer
    Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
    Signal Point Clinical Research Center
    Middletown, Ohio 45042
    Non-Small-Cell Lung Carcinoma
    Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Breast Cancer, Cancer Survivor, Hot Flashes
    A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
    Signal Point Clinical Research Center, LLC
    Middletown, Ohio 45042
    Colorectal Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Signal Point Clinical Research Center, LLC
    Middletown, Ohio 45042
    Colorectal Cancer
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Signal Point Clinical Research Center
    Middletown, Ohio 45042
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
    Investigational Site Number 840003
    Middletown, Ohio 45042
    Small Cell Lung Cancer
    Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
    Investigational Site Number 840019
    Middletown, Ohio 45042
    Hematopoietic Neoplasm
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    Signal Point Clinical Research Center, LLC
    Middletown, Ohio 45042
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    Signal Point Clinical Research Center, Site #139
    Middletown, Ohio 45042
    Chronic Myeloid Leukemia
    A Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
    Signal Point Clinical Research Center, LLC
    Middletown, Ohio 45042
    Indolent Non-Hodgkin's Lymphomas
    Phase 1 SAR650984 Combination With Lenalidomide
    Investigational Site Number 840003
    Middletown, Ohio 45042
    Multiple Myeloma
    Ohio Colorectal Cancer Prevention Initiative
    Atrium Medical Center
    Middletown, Ohio 45005
    Lynch Syndrome, Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Melanoma (Skin)
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Bladder Cancer
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Head and Neck Cancer
    Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Colorectal Cancer, Metastatic Cancer
    Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Pain, Unspecified Adult Solid Tumor, Protocol Specific
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Lung Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Pancreatic Cancer
    Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
    Middletown Regional Hospital
    Middletown, Ohio 45044
    Breast Cancer